136 related articles for article (PubMed ID: 32502287)
1. Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfall.
Pezzuto F; Fortarezza F; Mammana M; Pasello G; Pelosi G; Rea F; Calabrese F
Histopathology; 2020 Sep; 77(3):508-510. PubMed ID: 32502287
[No Abstract] [Full Text] [Related]
2. Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers.
Hung YP; Chen AL; Taylor MS; Huynh TG; Kem M; Selig MK; Nielsen GP; Lennerz JK; Azzoli CG; Dagogo-Jack I; Kradin RL; Mino-Kenudson M
Histopathology; 2021 May; 78(6):896-904. PubMed ID: 33231320
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.
Derks JL; Speel EJ; Thunnissen E; van Suylen RJ; Buikhuisen WA; van Velthuysen ML; Dingemans AM
J Thorac Oncol; 2016 Mar; 11(3):e35-8. PubMed ID: 26723240
[TBL] [Abstract][Full Text] [Related]
4. Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.
Shimizu K; Goto Y; Kawabata-Iwakawa R; Ohtaki Y; Nakazawa S; Yokobori T; Obayashi K; Kawatani N; Yajima T; Kaira K; Mogi A; Hirato J; Nishiyama M; Shirabe K
Ann Thorac Surg; 2019 Jul; 108(1):235-243. PubMed ID: 30910656
[TBL] [Abstract][Full Text] [Related]
5. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
7. The value of immunohistochemical identification of neuroendocrine differentiation in non small cell lung carcinoma.
Słodkowska J
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():23-7. PubMed ID: 9337520
[TBL] [Abstract][Full Text] [Related]
8. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical evaluation of large cell neuroendocrine carcinoma of the lung.
Endo C; Honda M; Sakurada A; Sato M; Saito Y; Kondo T
Acta Cytol; 2009; 53(1):36-40. PubMed ID: 19248553
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations.
Kudo K; Ohyanagi F; Horiike A; Miyauchi E; Yanagitani N; Hoshi R; Satoh Y; Motoi N; Hamanaka W; Ishikawa Y; Mun M; Sakao Y; Okumura S; Nakagawa K; Horai T; Nishio M
Lung Cancer; 2011 Dec; 74(3):401-4. PubMed ID: 21529988
[TBL] [Abstract][Full Text] [Related]
12. Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
Sholl LM; Long KB; Hornick JL
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):55-61. PubMed ID: 19661786
[TBL] [Abstract][Full Text] [Related]
13. [p40 Negative Basaloid Squamous Cell Carcinoma of the Lung;Report of a Case].
Maki R; Sugita S; Ono Y; Miyajima M; Tada M; Takahashi Y; Mishina T; Watanabe A
Kyobu Geka; 2018 Jul; 71(7):547-550. PubMed ID: 30042259
[TBL] [Abstract][Full Text] [Related]
14. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.
Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP;
Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401
[No Abstract] [Full Text] [Related]
15. Diagnostic and Predictive Immunohistochemistry for Non-Small Cell Lung Carcinomas.
Hung YP; Sholl LM
Adv Anat Pathol; 2018 Nov; 25(6):374-386. PubMed ID: 30188361
[TBL] [Abstract][Full Text] [Related]
16. A rare neuroendocrine tumor of the lung.
Karnan A
Pan Afr Med J; 2023; 46():54. PubMed ID: 38223878
[No Abstract] [Full Text] [Related]
17. Does Strong and Diffuse PAX-8 Positivity Occur in Primary Lung Carcinoma? An Immunohistochemical Study of 418 Cases and Review of the Literature.
McHugh KE; Arrossi AV; Farver CF; Mukhopadhyay S
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):140-146. PubMed ID: 28777151
[TBL] [Abstract][Full Text] [Related]
18. Challenging Diagnosis in NUT Carcinoma.
Claudia G; Alexandra G
Int J Surg Pathol; 2021 Oct; 29(7):722-725. PubMed ID: 34106022
[TBL] [Abstract][Full Text] [Related]
19. A typical presentation of primary pulmonary epithelioid sarcoma misdiagnosed as non-small cell lung cancer.
Emori M; Tamakawa M; Kaya M; Takada K; Murase K; Fujita C; Sato S; Takahashi R; Hatanaka KC; Sugita S; Hirano H; Yamashita T; Hasegawa T
Pathol Int; 2017 Apr; 67(4):222-224. PubMed ID: 28078765
[No Abstract] [Full Text] [Related]
20. Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis.
Wiatrowska BA; Krol J; Zakowski MF
Diagn Cytopathol; 2001 Jan; 24(1):58-64. PubMed ID: 11135471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
